94 related articles for article (PubMed ID: 7363859)
21. Direct inhibitory effect of long term estradiol treatment on dopamine synthesis in tuberoinfundibular dopaminergic neurons: in vitro studies using hypothalamic slices.
Arita J; Kimura F
Endocrinology; 1987 Aug; 121(2):692-8. PubMed ID: 3036480
[TBL] [Abstract][Full Text] [Related]
22. Involvement of adenohypophysial dopamine in the regulation of prolactin release during suckling.
Chiocchio SR; Cannata MA; Funes JR; Tramezzani JH
Endocrinology; 1979 Aug; 105(2):544-7. PubMed ID: 456329
[TBL] [Abstract][Full Text] [Related]
23. Morphine and naloxone: effects on beta-endorphin immunoreactivity in canine plasma and secretions from rat pituitaries.
Levin ER; Sharp B; Meyer NV; Carlson HE
Endocrinology; 1981 Jul; 109(1):146-51. PubMed ID: 6263581
[TBL] [Abstract][Full Text] [Related]
24. Influence of prolactin on dopaminergic neuronal systems in the hypothalamus.
Moore KE; Demarest KT; Johnston CA
Fed Proc; 1980 Sep; 39(11):2912-6. PubMed ID: 7409209
[TBL] [Abstract][Full Text] [Related]
25. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
Arita J; Kimura F
Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
[TBL] [Abstract][Full Text] [Related]
26. An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neurons.
Reymond MJ; Kaur C; Porter JC
Brain Res; 1983 Mar; 262(2):253-8. PubMed ID: 6404502
[TBL] [Abstract][Full Text] [Related]
27. Immediate release of prolactin and biphasic effects on growth hormone release following electrical stimulation of the median eminence.
Malven PV
Endocrinology; 1975 Oct; 97(4):808-15. PubMed ID: 1104350
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic neurotransmitter function in experimentally induced hyperprolactinemia.
Peñalva A; Novelli A; Parenti M; Locatelli V; Müller EE; Cocchi D
Brain Res; 1984 Dec; 324(2):233-41. PubMed ID: 6099203
[TBL] [Abstract][Full Text] [Related]
29. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1.
Rance N; Wise PM; Selmanoff MK; Barraclough CA
Endocrinology; 1981 May; 108(5):1795-802. PubMed ID: 6783392
[TBL] [Abstract][Full Text] [Related]
30. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro.
Fagin KD; Neill JD
Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383
[TBL] [Abstract][Full Text] [Related]
31. Evidence that thyrotropin-releasing hormone and a hypothalamic prolactin-releasing factor may function in the release of prolactin in the lactating rat.
Grosvenor CE; Mena F
Endocrinology; 1980 Oct; 107(4):863-8. PubMed ID: 6773747
[TBL] [Abstract][Full Text] [Related]
32. Enhanced dopamine synthesis and release in vitro in the median eminence of rat hypothalamus are associated with involution of estradiol-induced pituitary tumors.
Arita J; Kojima Y; Kimura F
Endocrinology; 1989 Apr; 124(4):1998-2004. PubMed ID: 2924731
[TBL] [Abstract][Full Text] [Related]
33. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin.
Székács D; Bodnár I; Mravec B; Kvetnansky R; Vizi ES; Nagy GM; Fekete MI
Neurochem Int; 2007 Jan; 50(2):427-34. PubMed ID: 17141375
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
Wang J; Ciofi P; Crowley WR
Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
[TBL] [Abstract][Full Text] [Related]
35. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
Krulich L; McCann SM; Mayfield MA
Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of prolactin-releasing activity from thyrotropin-releasing hormone in porcine stalk median eminence.
Szabo M; Frohman LA
Endocrinology; 1976 Jun; 98(6):1451-9. PubMed ID: 819252
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
Demarest KT; Riegle GD; Moore KE
Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
[TBL] [Abstract][Full Text] [Related]
38. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
Schmauss C; Emrich HM
Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
[TBL] [Abstract][Full Text] [Related]
39. Rapid effects of hyperprolactinemia on basal prolactin secretion and dopamine turnover in the medial and lateral median eminence.
Selmanoff M
Endocrinology; 1985 May; 116(5):1943-52. PubMed ID: 3921346
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of prolactin secretion from tuberoinfundibular dopamine activity in late pregnant rats.
Andrews ZB; Kokay IC; Grattan DR
Endocrinology; 2001 Jun; 142(6):2719-24. PubMed ID: 11356724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
